Form D · Biotechnology
MedicaMetrix, Inc.
Wayland, MA · CIK 0001565830
Offering snapshot reported Jan 3, 2013 · SEC filing
- Reported sold
- $1.63M Offering amount: $3.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 20, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2013 | Initial | $1,631,710 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-189355
Offering and sale amounts reflect aggregate of Series A Preferred Stock sold to domestic and foreign investors.
Source: Form D, filed Jan 3, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Fanning | Director |
| Robert Horne | Director |
| Christopher La Farge | Director, Executive |
| Ernest Pomerantz | Director |
| Judson Pratt | Executive |
| Richard L. Trembowicz | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Old Sudbury Road
Wayland, MA, 01778
Wayland, MA, 01778